Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
NEW YORK (GenomeWeb) – PGXL Technologies today said that it has formed a partnership with NX PharmaGen under which the partners have created a research center focused on exosome analysis.
NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.
NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.
This article has been updated to include information about a competing product in the market.
PGXL, a Louisville, Ky.-based pharmacogenomics services provider, plans to introduce other AutoGenomics assays, such as its KRAS-BRAF test, in the future.
Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.
New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.
Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.
La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.
In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.